{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:15:32Z","timestamp":1791764132883,"version":"4.3.4"},"reference-count":58,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Internet Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mobile apps that implement disorder-specific psychotherapy for panic disorder (PD) with and without agoraphobia can be used in real-life situations that trigger symptoms and, therefore, are a promising novel therapeutic tool.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This randomized controlled trial aimed to expand the currently limited evidence base for the efficacy of mobile interventions for PD with and without agoraphobia by evaluating a mobile app focusing on interoceptive and in-vivo exposure therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>After establishing the diagnosis of PD with and without agoraphobia using a secure video communication platform, we randomized 111 adults to 3 equally sized groups: disorder-specific exposure therapy app, mindfulness meditation app unrelated to the disorder (active control condition), and waiting list (passive control condition). Participants used the apps in a self-guided manner. Additional psychotherapy was not allowed during the study. Self-reported PD with and without agoraphobia symptom severity was our primary outcome parameter and measured by the Panic and Agoraphobia Scale and symptom subset scales. Secondary outcome parameters included depressive symptoms and quality of life. We conducted assessments at baseline, after the intervention (allocation+5 wk), and at follow-up (allocation+13 wk).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We observed significantly lower overall PD with and without agoraphobia symptom severity in the exposure app group compared to waiting list post-treatment (\n                      <jats:italic>P<\/jats:italic>\n                      =.04, Cohen\n                      <jats:italic>d<\/jats:italic>\n                      =0.55) and at follow-up (\n                      <jats:italic>P<\/jats:italic>\n                      =.04, Cohen\n                      <jats:italic>d<\/jats:italic>\n                      =0.60). At follow-up, the exposure app group demonstrated significantly stronger improvements than the waiting list group in depressive symptoms (\n                      <jats:italic>P<\/jats:italic>\n                      =.007, Cohen\n                      <jats:italic>d<\/jats:italic>\n                      =0.75) and psychological quality of life (\n                      <jats:italic>P<\/jats:italic>\n                      =.01, Cohen\n                      <jats:italic>d<\/jats:italic>\n                      =0.63). We observed no significant differences between the exposure and the meditation apps in overall PD with and without agoraphobia symptom severity (post-treatment:\n                      <jats:italic>P<\/jats:italic>\n                      &gt;.99, follow-up:\n                      <jats:italic>P<\/jats:italic>\n                      =.84). In the exposure app group, 35% (n=11) of participants showed reliable improvement in overall PD with and without agoraphobia symptom severity at post-treatment (meditation app: n=2, 6%; waiting list: n=2, 7%;\n                      <jats:italic>P<\/jats:italic>\n                      =.002\n                      <jats:italic>)<\/jats:italic>\n                      . The dropout rate after 5 weeks was 14% (5\/37) in the exposure app group (meditation app: 3\/37, 8%; waiting list: 6\/37, 16%;\n                      <jats:italic>P<\/jats:italic>\n                      =.68). No adverse outcomes were reported in the exposure app group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings suggest that app-guided exposure therapy can be a useful further treatment option in addition to established psychological and pharmacological strategies. However, superiority compared to the disorder-unspecific meditation app remains unclear.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/76389","type":"journal-article","created":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T14:50:07Z","timestamp":1756565407000},"page":"e76389-e76389","source":"Crossref","is-referenced-by-count":2,"title":["Mobile App\u2013Guided Exposure Therapy for Panic Disorder With and Without Agoraphobia: Randomized Controlled Trial"],"prefix":"10.2196","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6394-9342","authenticated-orcid":false,"given":"Matthias","family":"Guth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6434-3553","authenticated-orcid":false,"given":"Annika","family":"Wiebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4098-8477","authenticated-orcid":false,"given":"Mogda","family":"Ekhlas-Schumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3500-9360","authenticated-orcid":false,"given":"Alexa","family":"Rodenjohann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9336-7140","authenticated-orcid":false,"given":"Felicia","family":"Rohlfsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3310-1844","authenticated-orcid":false,"given":"Jacqueline","family":"Buchholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4117-8265","authenticated-orcid":false,"given":"Benjamin","family":"Selaskowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6876-518X","authenticated-orcid":false,"given":"Alexandra","family":"Philipsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9392-1244","authenticated-orcid":false,"given":"Niclas","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"R1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). 5th ed. American Psychiatric Publishing; 2013. [doi: 10.1176\/appi.books.9780890425596]","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"12","key":"R2","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/da.22572","article-title":"Cross-national epidemiology of panic disorder and panic attacks in the world mental health surveys","volume":"33","author":"de Jonge","journal-title":"Depress Anxiety"},{"issue":"6","key":"R3","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/da.22885","article-title":"A comparison of DSM-5 and DSM-IV agoraphobia in the World Mental Health Surveys","volume":"36","author":"Roest","journal-title":"Depress Anxiety"},{"key":"R4","unstructured":"Clinical guideline: generalised anxiety disorder and panic disorder in adults. National Institute for Health and Care Excellence (NICE). 2020. URL: https:\/\/www.nice.org.uk\/guidance\/cg113 [Accessed 27-10-2025]"},{"issue":"12","key":"R5","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1177\/0004867418799453","article-title":"Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised anxiety disorder","volume":"52","author":"Andrews","journal-title":"Aust N Z J Psychiatry"},{"key":"R6","unstructured":"Bandelow B Aden I Alpers GW Benecke C Deckert J Domschke K et al. Deutsche S3-Leitlinie: Behandlung von Angstst\u00f6rungen [Web page in German]. AWMF Leitlinien-Register. 2021. URL: https:\/\/register.awmf.org\/de\/leitlinien\/detail\/051-028 [Accessed 27-10-2025]"},{"issue":"Suppl 1","key":"R7","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-14-S1-S1","article-title":"Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders","volume":"14 Suppl 1","author":"Katzman","journal-title":"BMC Psychiatry"},{"key":"R8","unstructured":"Bandelow B . Panik- und Agoraphobie-Skala [Book in German]. 2nd ed. Hogrefe; 2016."},{"issue":"12","key":"R9","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1017\/S0033291717003919","article-title":"Dismantling cognitive-behaviour therapy for panic disorder: a systematic review and component network meta-analysis","volume":"48","author":"Pompoli","journal-title":"Psychol Med"},{"issue":"1","key":"R10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/wps.20083","article-title":"Advantages and limitations of Internet-based interventions for common mental disorders","volume":"13","author":"Andersson","journal-title":"World Psychiatry"},{"issue":"2","key":"R11","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1027\/1016-9040\/a000318","article-title":"Internet- and Mobile-Based Psychological Interventions: Applications, Efficacy, and Potential for Improving Mental Health","volume":"23","author":"Ebert","journal-title":"Eur Psychol"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.06.059","article-title":"Are Internet- and mobile-based interventions effective in adults with diagnosed panic disorder and\/or agoraphobia? A systematic review and meta-analysis","volume":"276","author":"Domhardt","journal-title":"J Affect Disord"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1016\/j.invent.2021.100364","article-title":"Disorder-specific internet-based cognitive-behavioral therapy in treating panic disorder, comorbid symptoms and improving quality of life: A meta-analytic evaluation of randomized controlled trials","volume":"24","author":"Polak","journal-title":"Internet Interv"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1016\/j.janxdis.2016.09.012","article-title":"Guided and unguided Acceptance and Commitment Therapy for social anxiety disorder and\/or panic disorder provided via the Internet and a smartphone application: A randomized controlled trial","volume":"44","author":"Ivanova","journal-title":"J Anxiety Disord"},{"issue":"11","key":"R15","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.7747","article-title":"Two Novel Cognitive Behavioral Therapy-Based Mobile Apps for Agoraphobia: Randomized Controlled Trial","volume":"19","author":"Christoforou","journal-title":"J Med Internet Res"},{"key":"R16","unstructured":"Margraf J Cwik JC . Mini-DIPS Open Access: Diagnostisches Kurzinterview bei psychischen St\u00f6rungen [Book in German]. OMP Ruhr-Universit\u00e4t Bochum; 2017. URL: https:\/\/omp.ub.rub.de\/index.php\/RUB\/catalog\/book\/102 [Accessed 27-10-2025]"},{"key":"R17","unstructured":"RED connect [Website in German]. URL: https:\/\/www.redmedical.de\/ [Accessed 27-10-2025]"},{"key":"R18","unstructured":"SosciSurvey [Website in German]. URL: https:\/\/www.soscisurvey.de\/ [Accessed 27-10-2025]"},{"key":"R19","unstructured":"Guideline on clinical investigation of medicinal products indicated for the treatment of panic disorder. European Medicines Agency; Jan 9, 2005. URL: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-clinical-investigation-medicinal-products-indicated-treatment-panic-disorder_en.pdf [Accessed 09-01-2024]"},{"issue":"5","key":"R20","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1176\/ajp.155.5.603","article-title":"Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder","volume":"155","author":"Broocks","journal-title":"Am J Psychiatry"},{"issue":"3","key":"R21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0887-6185(02)00257-8","article-title":"The role of catastrophic misinterpretation of bodily sensations and panic self-efficacy in predicting panic severity","volume":"18","author":"Casey","journal-title":"J Anxiety Disord"},{"issue":"12","key":"R22","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s00228-011-1073-9","article-title":"Determinants of pharmacodynamic trajectory of the therapeutic response to paroxetine in Japanese patients with panic disorder","volume":"67","author":"Ishiguro","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"R23","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1037\/\/0022-006x.52.6.1090","article-title":"Assessment of fear of fear in agoraphobics: the body sensations questionnaire and the agoraphobic cognitions questionnaire","volume":"52","author":"Chambless","journal-title":"J Consult Clin Psychol"},{"issue":"1","key":"R24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/BF01178486","article-title":"Fear of fear and the anxiety disorders","volume":"13","author":"Chambless","journal-title":"Cogn Ther Res"},{"key":"R25","unstructured":"Ehlers A Margraf J AKV . Fragebogen zu k\u00f6rperbezogenen \u00c4ngsten, Kognitionen und Vermeidung [Book in German]. 2nd ed. Beltz Test GmbH; 2001."},{"issue":"1","key":"R26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0005-7967(85)90140-8","article-title":"The Mobility Inventory for Agoraphobia","volume":"23","author":"Chambless","journal-title":"Behav Res Ther"},{"issue":"4","key":"R27","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.beth.2011.03.001","article-title":"Psychometric properties of the mobility inventory for agoraphobia: convergent, discriminant, and criterion-related validity","volume":"42","author":"Chambless","journal-title":"Behav Ther"},{"issue":"8","key":"R28","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.janxdis.2014.09.010","article-title":"The role of safety behaviors in exposure-based treatment for panic disorder and agoraphobia: associations to symptom severity, treatment course, and outcome","volume":"28","author":"Helbig-Lang","journal-title":"J Anxiety Disord"},{"issue":"3","key":"R29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/(SICI)1099-0879(199809)5:3<177::AID-CPP166>3.0.CO;2-%23","article-title":"Assessment of strategies to manage or avoid perceived threats among panic disorder patients: the Texas Safety Maneuver Scale (TSMS)","volume":"5","author":"Kamphuis","journal-title":"Clin Psychology and Psychoth"},{"key":"R30","doi-asserted-by":"crossref","unstructured":"Lang T Helbig-Lang S Westphal D Gloster AT Wittchen HU . Expositionsbasierte Therapie der Panikst\u00f6rung mit Agoraphobie: Ein Behandlungsmanual. 2., aktualisierte Auflage. Hogrefe; 2018. [doi: 10.1026\/02867-000]","DOI":"10.1026\/02867-000"},{"key":"R31","unstructured":"WHOQOL user manual. World Health Organization. 1998. URL: https:\/\/iris.who.int\/bitstream\/handle\/10665\/77932\/WHO_HIS_HSI_Rev.2012.03_eng.pdf [Accessed 27-10-2025]"},{"key":"R32","unstructured":"Angermeyer MC Kilian R Matschinger H . WHOQOL-BREF Deutsche Version. World Health Organization. 2000. URL: https:\/\/cdn.who.int\/media\/docs\/default-source\/publishing-policies\/whoqol-bref\/german-whoqol-bref.zip [Accessed 27-10-2025]"},{"key":"R33","doi-asserted-by":"crossref","unstructured":"Lovibond SH Lovibond P . Manual for the Depression Anxiety Stress Scales. 2nd ed. Psychology Foundation; 1995.","DOI":"10.1037\/t01004-000"},{"issue":"6","key":"R34","doi-asserted-by":"publisher","DOI":"10.1007\/s00482-015-0019-z","article-title":"Die Depressions-Angst-Stress-Skalen: Der DASS \u2013 ein Screeningverfahren nicht nur f\u00fcr Schmerzpatienten [Article in German]","volume":"29","author":"Nilges","journal-title":"Schmerz"},{"issue":"2","key":"R35","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1037\/1040-3590.19.2.176","article-title":"Robust dimensions of anxiety sensitivity: development and initial validation of the Anxiety Sensitivity Index-3","volume":"19","author":"Taylor","journal-title":"Psychol Assess"},{"issue":"4","key":"R36","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1026\/0012-1924.55.4.223","article-title":"\u00dcberpr\u00fcfung der psychometrischen Qualit\u00e4t der deutschen Version des Angstsensitivit\u00e4tsindex-3 [Article in German]","volume":"55","author":"Kemper","journal-title":"Diagnostica"},{"key":"R37","unstructured":"Kemper CJ Ziegler M Taylor S . ASI-3. Angstsensitivit\u00e4tsindex-3. ZPID. 2011. URL: https:\/\/doi.org\/10.23668\/psycharchives.4526 [Accessed 30-10-2025]"},{"key":"R38","doi-asserted-by":"crossref","unstructured":"Schwarzer R Jerusalem M . Generalized Self-Efficacy Scale Meas Health Psychol User\u2019s Portf Causal Control Belief. NFER-NELSON; 1995:35-37.","DOI":"10.1037\/t00393-000"},{"key":"R39","unstructured":"Jerusalem M Schwarzer R . General Self-Efficacy Scale (GSE) [Web page in German]. FUB-IT. 2012. URL: http:\/\/userpage.fu-berlin.de\/~health\/selfscal.htm [Accessed 27-10-2025]"},{"key":"R40","unstructured":"Schwarzer R Jerusalem M , editors. Skalen zur Erfassung von Lehrer- und Sch\u00fclermerkmalen: Dokumentation der psychometrischen Verfahren im Rahmen der Wissenschaftlichen Begleitung des Modellversuchs Selbstwirksame Schulen [Book in German]. Freie Universit\u00e4t Berlin; 1999."},{"key":"R41","unstructured":"Mindable: Panic & Agoraphobia. URL: https:\/\/www.mindable.health\/ [Accessed 27-10-2025]"},{"key":"R42","unstructured":"Mindable: Panik & Agoraphobie. DiGA-Verzeichnis. URL: https:\/\/diga.bfarm.de\/de\/verzeichnis\/00329 [Accessed 27-10-2025]"},{"key":"R43","unstructured":"7Mind [Website in German]. URL: https:\/\/www.7mind.de\/ [Accessed 27-10-2025]"},{"key":"R44","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2018.03.008","article-title":"Different ways to estimate treatment effects in randomised controlled trials","volume":"10","author":"Twisk","journal-title":"Contemp Clin Trials Commun"},{"issue":"1","key":"R45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1037\/0022-006X.59.1.12","article-title":"Clinical significance: a statistical approach to defining meaningful change in psychotherapy research","volume":"59","author":"Jacobson","journal-title":"J Consult Clin Psychol"},{"issue":"2","key":"R46","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/s0197-2456(00)00134-3","article-title":"Calculating confidence intervals for the number needed to treat","volume":"22","author":"Bender","journal-title":"Control Clin Trials"},{"key":"R47","unstructured":"R: a language and environment for statistical computing. R Foundation for Statistical Computing. URL: https:\/\/www.R-project.org\/ [Accessed 27-10-2025]"},{"issue":"1","key":"R48","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","journal-title":"J Stat Softw"},{"key":"R49","unstructured":"CRAN: package emmeans. The Comprehensive R Archive Network. URL: https:\/\/CRAN.R-project.org\/package=emmeans [Accessed 27-10-2025]"},{"key":"R50","unstructured":"Cohen J . Statistical Power Analysis for the Behavioral Sciences. Routledge; 1988. URL: https:\/\/www.taylorfrancis.com\/books\/9781134742707 [Accessed 27-10-2025]"},{"issue":"1","key":"R51","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s10608-024-10513-w","article-title":"A smart solution? Efficacy of a self-management smartphone app for panic disorder and agoraphobia","volume":"49","author":"Spies","journal-title":"Cogn Ther Res"},{"issue":"6","key":"R52","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/s0005-7967(98)00153-3","article-title":"An experimental investigation of the role of safety-seeking behaviours in the maintenance of panic disorder with agoraphobia","volume":"37","author":"Salkovskis","journal-title":"Behav Res Ther"},{"issue":"7","key":"R53","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1176\/ajp.149.7.936","article-title":"Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders","volume":"149","author":"Kabat-Zinn","journal-title":"Am J Psychiatry"},{"issue":"10","key":"R54","first-page":"620","volume":"99","author":"Saeed","journal-title":"Am Fam Physician"},{"issue":"37\u201344","key":"R55","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.psychres.2016.07.007","article-title":"Toward an understanding of the quality of life construct: validity and reliability of the WHOQOL-Bref in a psychiatric sample","volume":"244","author":"Oliveira","journal-title":"Psychiatry Res"},{"issue":"9","key":"R56","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.brat.2008.06.010","article-title":"The efficacy of cognitive-behavioral interventions for reducing anxiety sensitivity: a meta-analytic review","volume":"46","author":"Smits","journal-title":"Behav Res Ther"},{"issue":"11","key":"R57","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.brat.2013.09.001","article-title":"Mechanisms of change in cognitive behavioral therapy for panic disorder: the unique effects of self-efficacy and anxiety sensitivity","volume":"51","author":"Gallagher","journal-title":"Behav Res Ther"},{"key":"R58","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291722003683","article-title":"CBT treatment delivery formats for panic disorder: a systematic review and network meta-analysis of randomised controlled trials","volume":"53(3)","author":"Papola","journal-title":"Psychol Med"}],"container-title":["Journal of Medical Internet Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jmir.org\/2025\/1\/e76389","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:07:54Z","timestamp":1782842874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmir.org\/2025\/1\/e76389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":58,"URL":"https:\/\/doi.org\/10.2196\/76389","relation":{},"ISSN":["1438-8871"],"issn-type":[{"value":"1438-8871","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"article-number":"v27i12e76389"}}